Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience
Background and study aims: Endoscopic submucosal dissection (ESD) carries significant advantages over endoscopic mucosal resection. As such, ESD is an established therapy for esophageal squamous cell carcinoma but there are only limited data on ESD as therapy for Barrett’s esophagus (BE). Thus, we...
Main Authors: | , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
© Georg Thieme Verlag KG
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993890/ |
id |
pubmed-4993890 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-49938902016-08-23 Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience Coman, Roxana M. Gotoda, Takuji Forsmark, Christopher E. Draganov, Peter V. Background and study aims: Endoscopic submucosal dissection (ESD) carries significant advantages over endoscopic mucosal resection. As such, ESD is an established therapy for esophageal squamous cell carcinoma but there are only limited data on ESD as therapy for Barrett’s esophagus (BE). Thus, we prospectively evaluated the outcomes of ESD in patients with BE with high-grade dysplasia (HGD) and early esophageal adenocarcinoma (EAC) performed in a Western center. © Georg Thieme Verlag KG 2016-06 2016-03-30 /pmc/articles/PMC4993890/ /pubmed/27556083 http://dx.doi.org/10.1055/s-0042-101788 Text en © Thieme Medical Publishers |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Coman, Roxana M. Gotoda, Takuji Forsmark, Christopher E. Draganov, Peter V. |
spellingShingle |
Coman, Roxana M. Gotoda, Takuji Forsmark, Christopher E. Draganov, Peter V. Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience |
author_facet |
Coman, Roxana M. Gotoda, Takuji Forsmark, Christopher E. Draganov, Peter V. |
author_sort |
Coman, Roxana M. |
title |
Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience |
title_short |
Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience |
title_full |
Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience |
title_fullStr |
Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience |
title_full_unstemmed |
Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience |
title_sort |
prospective evaluation of the clinical utility of endoscopic submucosal dissection (esd) in patients with barrett’s esophagus: a western center experience |
description |
Background and study aims: Endoscopic submucosal dissection (ESD) carries significant advantages over endoscopic mucosal resection. As such, ESD is an established therapy for esophageal squamous cell carcinoma but there are only limited data on ESD as therapy for Barrett’s esophagus (BE). Thus, we prospectively evaluated the outcomes of ESD in patients with BE with high-grade dysplasia (HGD) and early esophageal adenocarcinoma (EAC) performed in a Western center. |
publisher |
© Georg Thieme Verlag KG |
publishDate |
2016 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993890/ |
_version_ |
1613632270689632256 |